Showing results (2021-2030 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|February 1, 1989
Phase II trial of intermediate dose ARA-C (IDAC) with sequential mitoxantrone (MITOX) in acute myelogenous leukemiaS Amadori, G Meloni, M C Petti, et al.
Leukemia|February 1, 1989
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocolE Berman, Z A Arlin, J Gaynor, et al.
Leukemia|November 1, 1988
A rare restriction enzyme site polymorphism in the breakpoint cluster region (bcr) of chromosome 22P Benn, A Grossman, L Soper, et al.
Leukemia|November 4, 2017
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapyV K Patel, B Lamothe, M L Ayres, et al.
Leukemia|August 26, 2017
Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T CellsY Lai, J Weng, X Wei, et al.
Leukemia|September 19, 2017
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chainsS Sidana, N Tandon, A Dispenzieri, et al.
Leukemia|September 23, 2017
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathwaysD Benedetti, E Tissino, F Pozzo, et al.
Leukemia|September 28, 2017
A compound chimeric antigen receptor strategy for targeting multiple myelomaK H Chen, M Wada, K G Pinz, et al.
Leukemia|July 1, 1988
Membrane transferrin receptor (TfR) and nuclear proliferation-associated Ki-67 expression in hemopoietic malignanciesC S Scott, W Ramsden, H J Limbert, et al.
Leukemia|August 30, 2017
Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantationR Chakraborty, E Muchtar, S K Kumar, et al.
Pageof 963